Prediction Case File
YouTubeEvaluation Complete

Arcus Biosciences Inc. Stock Prediction and Forecast [RCUS]

1 extracted signal · 1 resolved · 0 still active

StockInvest.us profile imageStockInvest.usIndependent analyst profile
Source published
13 Dec 2025, 04:30 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for Arcus Biosciences Inc. Stock Prediction and Forecast [RCUS]
Source overview

AI-generated source summary

The analysis for Arcus Biosciences Inc. (RCUS) stock designates it as a Strong Sell Candidate with an overall system score of -5.056. The current price is $21.53, reflecting a 14.45% decline on the last trading day. News indicates a significant plunge due to the halting of a Phase 3 cancer study, serving as an immediate negative catalyst, despite a prior 300% run-up. Management plans to reallocate resources to other programs, and increased volatility and potential additional selling are anticipated. The company recently completed a $250 million equity raise with new inducement grants. Executive stock sales and a recent quarterly loss contribute to a cautious sentiment. Technical signals present a mixed picture: short-term indicators include a buy signal from MACD and Bollinger Bands, while Pivots and Long Moving Average indicate sell signals. Long-term Moving Averages show a sell signal from the Short MA (2 days ago), and buy signals from the Long MA (112 days ago) and Cross MA35/MA100 (104 days ago). The stock exhibits high weekly volatility at 7.11%. Immediate resistance levels are identified at $24.28 and $25.43, with support levels at $20.35 and $20.29. The Price-to-Earnings (P/E) ratio is negative at -6.57. Insider trading indicates a positive insider power of 78.395, with more shares purchased (7.498 million) than sold (558,540) in the last 100 transactions. The conclusion forecasts weak performance for RCUS in the next few days or weeks, reiterating a negative evaluation and a downgrade from Buy to Strong Sell. Although the stock is considered undervalued and is predicted to open higher on the next trading day by $0.427, trading at $21.95, the overarching sentiment points to further decline. An inferred short-term target price is $20.29, with a failure bound at $24.28, reflecting a bearish predicted trend for the upcoming week.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
0
Resolved successfully
Failed
1
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
0%
1 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Analyst snapshot

StockInvest.us

Platform-wide history, separate from this source evaluation.

Reliability
53.4
Tracked signals
1779
Historical success
42.8%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail